Literature DB >> 1086079

Abnormal lymphocyte function is secondary to drug-induced autoimmunity.

S Pugh, B Pelton, E B Raftery, A M Denman.   

Abstract

Abnormal lymphocyte function has been frequently reported in patients with connective tissue diseases but its significance has been uncertain. Sequential studies of lymphocyte function were carried out in patients receiving the beta-adrenergic blocking drug practolol (Eraldin) both before and during the development of autoimmune complications. No evidence was obtained that abnormal lymphocyte function presaged the onset of autoimmunity, and when these tests did show deficient responses these could be correlated with disease activity in general.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086079      PMCID: PMC1007393          DOI: 10.1136/ard.35.4.344

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

2.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

3.  Cell surface markers for human T and B lymphocytes.

Authors:  G Brown; M F Greaves
Journal:  Eur J Immunol       Date:  1974-04       Impact factor: 5.532

Review 4.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  Immunologic reactivity in rheumatoid arthritis. Response to mitogens.

Authors:  E M Lance; S C Knight
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

6.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

7.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

8.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
View more
  1 in total

Review 1.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.